Metabolism & Elimination GLP2 undergoes metabolism through pathways typical of peptide therapeutics: Plasma half-life of approximately 5 days in humans, enabling once-weekly administration Primary metabolic pathways include proteolytic cleavage of the peptide backbone, beta-oxidation of the C20 fatty diacid moiety, and amide hydrolysis Not metabolized via cytochrome P450 enzymes, sulfation, or glucuronidation pathways Low potential for drug-drug interactions mediated through hepatic metabolism or transporter systems The extended half-life represents a key pharmacokinetic advantage, with steady-state accumulation of approximately 1.7-fold enabling consistent therapeutic exposure throughout the dosing interval
Pills are also easier to manufacture than injectable pens, which could help avoid the frustrating supply problems that slowed earlier GLP-1 launches
Mauris vitae nisl in ante commodo pretium
Promotes Muscle and Bone HealthCollagen and vitamin C work synergistically to maintain muscle mass and bone strength, especially important for active lifestyles
At the time of the assay, the culture medium was replaced with Seahorse XF assay medium supplemented with glucose and glutamine, and cells were equilibrated for 1 hour in a non-CO incubator
PcoA, Principal Coordinates Analysis